7BG-14493-24902

3 vaccinations 6 coded responses 34 check-ins 6 free-text entries 1 call case

Sex: Female
Age at first dose: 0-4
ZIP prefix: 919 / CA
Registered: 2022-06-30

Relationship: Child or adolescent in my care
Guardian: PN6-33091-18427
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-30
Registered in v-safe
2022-06-30
Dose 1 — Pfizer-BioNTech
2022-06-30
Health check-in — day 0, dose 1, under 3
Feeling: Poor · Fever · Irritability/crying · Be unable to do your normal daily activities

Under 3 check-in
2022-07-01
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Poor · Fever · Irritability/crying, Loss of appetite, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Under 3 check-in
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Poor · Site: Swelling/hardness · Fever · Sleepiness, Irritability/crying, Loss of appetite, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Under 3 check-in
2022-07-03
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Poor · Fever · Sleepiness, Loss of appetite · Be unable to work or attend school

Under 3 check-in
2022-07-04
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite, Diarrhea · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Under 3 check-in
2022-07-04
Report sent to call center — days 1–6 daily, dose 1, under 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-07-05
Call 1 — Could Not Reach Participant
2022-07-06
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activities

Under 3 check-in
2022-07-08
Call 2 — Left Voicemail
2022-07-08
Callback requested for
12:40PM ET
2022-07-08
Call successful
Not applicable - Accidental Reporting
2022-07-09
Health check-in — day 7, dose 1, under 3
Feeling: Fair · Sleepiness · Be unable to work or attend school

Under 3 check-in
2022-07-14
Health check-in — day 14, dose 1, under 3
Feeling: Fair

Under 3 check-in
2022-07-21
Survey response — day 21, dose 1, under 3
MedDRA: Conjunctivitis viral, Cough — Feeling: Fair

Free text: Suspect viral conjunctivitis both eyes, cough

MedDRA releases: 2024-11 · check-in free text available
2022-07-28
Dose 2 — Pfizer-BioNTech
2022-07-28
Health check-in — day 0, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-07-29
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-07-30
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-07-31
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-01
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-02
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-03
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-04
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-11
Survey response — day 14, dose 2, under 3
MedDRA: Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Fever, congestion

MedDRA releases: 2024-11 · check-in free text available
2022-08-18
Health check-in — day 21, dose 2, under 3
Feeling: Fair

Under 3 check-in
2022-08-25
Survey response — day 28, dose 2, under 3
MedDRA: Cough, Rhinorrhoea — Feeling: Fair

Free text: Runny nose, cough

MedDRA releases: 2024-11 · check-in free text available
2022-09-01
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-08
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-22
Dose 3 — Pfizer-BioNTech
2022-09-23
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Fair · Irritability/crying

Under 3 check-in
2022-09-24
Survey response — days 1–6 daily, dose 3, under 3
MedDRA: Lacrimation increased, Rhinorrhoea — Feeling: Fair

Free text: Runny nose, watery eyes

MedDRA releases: 2024-11 · check-in free text available
2022-09-25
Survey response — days 1–6 daily, dose 3, under 3
MedDRA: Rhinorrhoea — Feeling: Fair

Free text: Runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-09-27
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activities

Under 3 check-in
2022-09-29
Health check-in — day 7, dose 3, under 3
Feeling: Poor · Fever · Irritability/crying, Loss of appetite, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities

Under 3 check-in
2022-10-07
Health check-in — day 14, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-10-15
Survey response — day 21, dose 3, under 3
MedDRA: Cough, Nasal congestion — Feeling: Fair

Free text: Stuffy nose, cough

MedDRA releases: 2024-11 · check-in free text available
2022-10-21
Health check-in — day 28, dose 3, under 3
Feeling: Fair

Under 3 check-in
2022-10-31
Health check-in — day 35, dose 3, under 3
Feeling: Fair

Under 3 check-in
2022-11-03
Health check-in — day 42, dose 3, under 3
Feeling: Fair

Under 3 check-in
2022-12-22
Health check-in — 3 months, dose 3, under 3
Feeling: Fair

Under 3 check-in
2023-03-23
Health check-in — 6 months, dose 3, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-30	Pfizer-BioNTech	No
2	2022-07-28	Pfizer-BioNTech	No
3	2022-09-22	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 12 (Under 3) — day 21, dose 1, under 3

2022-07-21

Symptoms: Suspect viral conjunctivitis both eyes, cough

Release 12 (Under 3) — day 14, dose 2, under 3

2022-08-11

Symptoms: Fever, congestion

Release 12 (Under 3) — day 28, dose 2, under 3

2022-08-25

Symptoms: Runny nose, cough

Release 12 (Under 3) — days 1–6 daily, dose 3, under 3

2022-09-24

Systemic reaction (other): Runny nose, watery eyes

2022-09-25

Systemic reaction (other): Runny nose

Release 12 (Under 3) — day 21, dose 3, under 3

2022-10-15

Symptoms: Stuffy nose, cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Conjunctivitis viral	·	·	✓
SD	Cough	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓
SRO	Lacrimation increased	·	·	✓
SRO	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release